X0306 4 2016-07-21 0 0001455684 TPI COMPOSITES, INC TPIC 0001679525 Weiss Daniel G 2029 CENTURY PARK EAST SUITE 2980 LOS ANGELES CA 90067 1 0 1 0 Series B Warrants 8748.81 2016-07-21 4 X 0 16.5737 0.00 D Series B Convertible Preferred Stock 16.5737 0 I See Note Series B Convertible Preferred Stock 2016-07-21 4 X 0 16.5737 0.00 A Common Stock 21261 190.9977 I See Note Series B Convertible Preferred Stock 2016-07-21 4 S 0 10.2762 0.00 D Common Stock 13182 180.7215 I See Note The Series B Warrants were deemed automatically exercised prior to the closing of the Issuer's initial underwritten public offering of Common Stock pursuant to a registration statement on Form S-1, which public offering has been declared effective by the SEC. These securities were exercisable for a period ending upon the earliest to occur of (i) seven (7) years after the Effective Date, (ii) the date of the Issuer's initial public offering, or (iii) the date of a merger event, as defined therein. These securities are held of record by Angeleno Investors II, L.P ("AI II LP") and the Reporting Person has been designated as a representative to serve on the Issuer's board of directors by AI II LP and is the co-founder and managing partner of the Angeleno Group. The Reporting Person may be deemed to share voting and investment power with respect to all shares held by AI II LP. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. The Series B Convertible Preferred Stock (the "Series B Shares") is convertible at any time into shares of the Issuer's Common Stock at the holder's election and automatically convert, upon the closing of the Issuer's initial public offering, into the number of shares of Common Stock shown in column 7 above. These securities do not have an expiration date. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 10.2762 of the Series B Shares to pay the exercise price and issuing to the Reporting Person the remaining 180.7215 Series B Shares. /s/ Steven G. Fishbach, Attorney-in-Fact 2016-07-25